Saveleva Mariia S, Lobanov Mikhail E, Mayorova Oksana A
Science Medical Center, Saratov State University, Saratov, Russia.
Bio Protoc. 2024 Jul 5;14(13):e5027. doi: 10.21769/BioProtoc.5027.
Intravesical instillation is an efficient therapeutic technique based on targeted administration of a drug directly into the lesion for the treatment of bladder diseases. This is an alternative to traditional systemic administration of drugs. However, this technique requires repeated procedures, which can lead to even greater inflammation and infection of the urethra. To date, novel systems that allow prolonged drug retention in the bladder cavity are actively being developed. We recently reported a targeted drug delivery system based on the mucoadhesive emulsion microgels consisting of the natural component whey protein isolate. Such micron-sized carriers possess high loading capacity, a prolonged drug release profile, and efficient mucoadhesive properties to the bladder urothelium. As a continuation of this work, we present a protocol for the synthesis of mucoadhesive emulsion microgels. Detailed procedures for preparing precursor solutions as well as studying the physico-chemical parameters of microgels (including loading capacity and drug release rate) and the mucoadhesive properties using the model of porcine bladder urothelium are discussed. Precautionary measures and nuances that are worth paying attention to during each experimental stage are given as well. Key features • The protocol for the synthesis of mucoadhesive emulsion microgels based on whey protein isolate is presented. The experimental conditions of emulsion microgels synthesis are discussed. • Methods for studying the physico-chemical properties of mucoadhesive emulsion microgels (size of emulsion microgels particles, loading capacity, release kinetics) are described. • The method for assessing mucoadhesive properties of emulsion microgels is demonstrated using the porcine bladder tissue model ex vivo.
膀胱内灌注是一种基于将药物直接靶向给药至病灶来治疗膀胱疾病的有效治疗技术。这是传统药物全身给药的一种替代方法。然而,该技术需要重复操作,这可能导致尿道发生更严重的炎症和感染。迄今为止,能使药物在膀胱腔内长时间保留的新型系统正在积极研发中。我们最近报道了一种基于由天然成分乳清蛋白分离物组成的粘膜粘附性乳液微凝胶的靶向给药系统。这种微米级载体具有高载药量、延长的药物释放曲线以及对膀胱尿路上皮有效的粘膜粘附特性。作为这项工作的延续,我们提出了一种粘膜粘附性乳液微凝胶的合成方案。讨论了制备前驱体溶液的详细步骤,以及使用猪膀胱尿路上皮模型研究微凝胶的物理化学参数(包括载药量和药物释放速率)和粘膜粘附特性的详细步骤。还给出了在每个实验阶段值得注意的预防措施和细微差别。关键特性 • 提出了基于乳清蛋白分离物的粘膜粘附性乳液微凝胶的合成方案。讨论了乳液微凝胶合成的实验条件。 • 描述了研究粘膜粘附性乳液微凝胶物理化学性质(乳液微凝胶颗粒大小、载药量、释放动力学)的方法。 • 使用离体猪膀胱组织模型展示了评估乳液微凝胶粘膜粘附特性的方法。